PloS Medicine
See the following -
Big Pharma Plays Hide-The-Ball With Data
...[E]vidence released earlier this year by Cochrane Collaboration, a London-based nonprofit, shows that a significant amount of negative data from [Tamiflu's] clinical trials were hidden from the public. The Food and Drug Administration (FDA) knew about it, but the medical community did not; the U.S. Centers for Disease Control and Prevention (CDC), which doesn’t have the same access to unpublished data as regulators, had recommended the drug without being able to see the full picture...
- Login to post comments
MSF Pioneers Opening Up Access To Humanitarian Data
Médecins Sans Frontières (MSF) is pioneering an open-access approach within the humanitarian sector in the hope that other medical aid organisations will follow suit. Read More »
- Login to post comments
PLOS & DNDi Launch A New Collection Celebrating A Decade Of Open Access And NTD R&D
As part of a collaborative initiative, PLOS and the Drugs for Neglected Diseases initiative (DNDi) are delighted to launch a special Collection—PLOS & DNDi: a decade of Open Access and Neglected Tropical Diseases R&D—to coincide with a joint event at the Institut Pasteur in Paris celebrating the 10 year anniversary of DNDi... Read More »
- Login to post comments
Poor Uptake By Healthcare Workers In mHealth Pilot Program
A pilot study of an app for mobile healthcare workers in a rural South African multidrug-resistant tuberculosis (MDR-TB) treatment program has valuable lessons for scaling new mHealth initiatives in other resource-constrained environments, concludes an article published in PLoS Medicine. Read More »
- Login to post comments